Health Care & Life Sciences » Pharmaceuticals | IntelGenx Technologies Corp.

IntelGenx Technologies Corp.

IntelGenx Technologies Corp.
Stock Exchange Other OTC
EPS
$0.13
Market Cap
$47.04 M
Shares Outstanding
93.45 M
Public Float
92.25 M
IntelGenx Technologies Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
70.03 M
Public Float
66.63 M
IntelGenx Technologies Corp.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.17
Market Cap
CAD62.61 M
Shares Outstanding
70.03 M
Public Float
66.63 M

Profile

Address
6420 Abrams
Ville Saint-Laurent Québec H4S 1X9
Canada
Employees -
Website http://www.intelgenx.com
Updated 07/08/2019
IntelGenx Technologies Corp. engages in the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. Its products include rizaport, tadalafil, loxapine, and montelukast. It also offers a comprehensive portfolio of pharmaceutical services, such as pharmaceutical research and development, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing.

Financials

View All

Horst G. Zerbe
Chairman, President & Chief Executive Officer
Mark H. Nawacki
Director